Abstract
Since Serial Analysis of Gene Expression (SAGE) was introduced more than a decade ago, it has been widely applied to characterise gene expression profiles in various tissues, cell types and cell lines of diverse origin including human, mouse, rat, yeast, plant and parasites. Throughout the past years many modifications to the original SAGE protocol have been developed, which address several aspects of SAGE, including an increase in sequencing efficiency (deep- SAGE), improved tag-to-transcript mapping of SAGE tags (LongSAGE) and a reduction of the amount of required input RNA (microSAGE). Furthermore, the applications of SAGE have expanded from exclusively transcriptome analysis to now also include genome analysis, identifying genome signature tags that pinpoint transcription factor binding sites throughout the genome (Serial Analysis of Chromatin Occupancy or SACO). The review gives an overview of the main modifications to the SAGE technology that have been developed in the last decade, with a particular focus on the large reduction in the amount of required input RNA that has been achieved in the many SAGE modifications for downscaling or miniaturisation of SAGE (including microSAGE, PCR-SAGE and small amplified RNA-SAGE). The available methods for downscaling or miniaturisation of SAGE and their specific features will be discussed, illustrated by some examples of their application. This reduction in required quantity of input RNA has greatly expanded the possible applications of SAGE, allowing characterisation of global gene expression in material obtained from needle biopsies, small anatomical structures and specific cell types isolated by fluorescence activated cell sorting or laser microdissection.
Keywords: SAGE, gene expression, downscaling, laser microdissection, microSAGE
Current Pharmaceutical Biotechnology
Title: Scaling Down SAGE: from miniSAGE to microSAGE
Volume: 9 Issue: 5
Author(s): N. A. Datson
Affiliation:
Keywords: SAGE, gene expression, downscaling, laser microdissection, microSAGE
Abstract: Since Serial Analysis of Gene Expression (SAGE) was introduced more than a decade ago, it has been widely applied to characterise gene expression profiles in various tissues, cell types and cell lines of diverse origin including human, mouse, rat, yeast, plant and parasites. Throughout the past years many modifications to the original SAGE protocol have been developed, which address several aspects of SAGE, including an increase in sequencing efficiency (deep- SAGE), improved tag-to-transcript mapping of SAGE tags (LongSAGE) and a reduction of the amount of required input RNA (microSAGE). Furthermore, the applications of SAGE have expanded from exclusively transcriptome analysis to now also include genome analysis, identifying genome signature tags that pinpoint transcription factor binding sites throughout the genome (Serial Analysis of Chromatin Occupancy or SACO). The review gives an overview of the main modifications to the SAGE technology that have been developed in the last decade, with a particular focus on the large reduction in the amount of required input RNA that has been achieved in the many SAGE modifications for downscaling or miniaturisation of SAGE (including microSAGE, PCR-SAGE and small amplified RNA-SAGE). The available methods for downscaling or miniaturisation of SAGE and their specific features will be discussed, illustrated by some examples of their application. This reduction in required quantity of input RNA has greatly expanded the possible applications of SAGE, allowing characterisation of global gene expression in material obtained from needle biopsies, small anatomical structures and specific cell types isolated by fluorescence activated cell sorting or laser microdissection.
Export Options
About this article
Cite this article as:
Datson A. N., Scaling Down SAGE: from miniSAGE to microSAGE, Current Pharmaceutical Biotechnology 2008; 9 (5) . https://dx.doi.org/10.2174/138920108785915120
DOI https://dx.doi.org/10.2174/138920108785915120 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics.
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
Machine Learning and Artificial Intelligence for Medical Data Analysis and Human Information Analysis in Healthcare
The intersection of machine learning (ML) and artificial intelligence (AI) with the pharmaceutical industry is revolutionizing traditional paradigms in drug discovery and development. These technologies have introduced innovative approaches to analyzing complex datasets and predicting chemical properties, leading to more efficient identification and optimization of drug candidates. By employing sophisticated ...read more

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma
Current Cancer Drug Targets Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design microRNAs in Stroke Pathogenesis
Current Molecular Medicine Cardiovascular Magnetic Resonance T2-weighted Imaging of Myocardial Edema in Acute Myocardial Infarction
Recent Patents on Cardiovascular Drug Discovery Mast Cells: Pivotal Players in Cardiovascular Diseases
Current Cardiology Reviews Analysis of Nitric Oxide (NO) in Cerebral Vasospasm After Aneursymal Bleeding
Reviews on Recent Clinical Trials Patients with Polyvascular Disease: A Very High-risk Group
Current Vascular Pharmacology The Association of Connective Tissue Disorders with Cervical Artery Dissections
Current Molecular Medicine Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science Static Cerebral Blood Flow Autoregulation in Humans
Current Hypertension Reviews Physical Function and Exercise in Older Patients with Cardiovascular and Respiratory Conditions
Current Pharmaceutical Design Takotsubo Cardiomyopathy
Current Pharmaceutical Design Glycosaminoglycans as Key Molecules in Atherosclerosis: The Role of Versican and Hyaluronan
Current Medicinal Chemistry Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Perioperative B-blockers in Non-cardiac Surgery: Actual Situation
Current Pharmaceutical Design Indications, Implications and Applications of Renal Denervation. Have we Discovered Something new?
Current Hypertension Reviews